Chiron Capital Management, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $108 Million distributed in 114 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $18.3M, Spdr Ser Tr Spdr S&P Biotech E with a value of $6.8M, Crown Castle International Corp with a value of $2.71M, Nike, Inc. with a value of $2.64M, and Aflac Inc with a value of $2.59M.

Examining the 13F form we can see an increase of $4.12M in the current position value, from $104M to 108M.

Below you can find more details about Chiron Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $108 Million
Healthcare: $30.2 Million
Consumer Defensive: $12.9 Million
ETFs: $12.5 Million
Consumer Cyclical: $9.5 Million
Communication Services: $8.49 Million
Technology: $7.66 Million
Energy: $6.33 Million
Financial Services: $6.31 Million
Other: $14.3 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 114
  • Current Value $108 Million
  • Prior Value $104 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 18 stocks
  • Additional Purchases 37 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 44 stocks
Track This Portfolio

Track Chiron Capital Management, LLC Portfolio

Follow Chiron Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.